Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 10, 2006. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on August 9, 2006. Each individual acquired 9 shares through the personal contribution element and 9 shares through the matching element of the Company's ShareReward Plan. The purchase price was GBP 14.22 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the share acquisitions described above.
Investor Verification Points
- Verify the share price of GBP 14.22 per Ordinary Share on August 9, 2006.
- Confirm the total number of shares acquired by each named director (18 shares per individual: 9 personal, 9 matched).
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the matching contribution structure.